Cover Image
Market Research Report

Precision Medicine Software - Global Market Outlook (2017-2026)

Published by Stratistics Market Research Consulting Product code 825538
Published Content info 171 Pages
Delivery time: 2-3 business days
Price
Back to Top
Precision Medicine Software - Global Market Outlook (2017-2026)
Published: March 1, 2019 Content info: 171 Pages
Description

According to Stratistics MRC, the Global Precision Medicine Software market is accounted for $0.87 billion in 2017 and is expected to reach $2.72 billion by 2026 growing at a CAGR of 13.5%. Some of the factors influencing the market growth are increase in the number of cancer patients, rising government funding in precision medicine initiatives and technological advancements in applications of big data technologies. However, the lack of skilled IT professionals in healthcare and the high cost of deployment are hindering the market growth.

Based on application, the oncology segment commanded significant market growth during the predicted period due to increased funding in cancer research and the rising occurrence of cancer. In addition, increase genomics-based clinical trials of targeted agents and immunotherapy is also fuelling the segment growth during the forecast period. Biomarkers have other specific applications in the field of oncology.

By geography, North America is anticipated to dominate the global market. The regional market growth is majorly driven by the rising HCIT investments in this region and increasing digitalization.

Some of the key players in the Precision Medicine Software market include 2bprecise, LLC, Gene42, Inc., Syapse, Inc., Human Longevity, Inc., Fabric Genomics, Inc., Translational Software Inc., Allscripts, Sophia Genetics Sa, Roper Technologies, Qiagen, Lifeomic Health, LLC and Pieriandx, Inc.

Delivery Modes Covered:

  • Cloud-Based Delivery Mode
  • On-Premise Delivery Mode

Applications Covered:

  • Pharmacogenomics
  • Rare Diseases
  • Oncology
  • Respiratory
  • Immunology
  • Central Nervous System (CNS)
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Healthcare Providers
  • Research Centers and Government Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub-segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Precision Medicine Software Market, By Delivery Mode

  • 5.1 Introduction
  • 5.2 Cloud-Based Delivery Mode
  • 5.3 On-Premise Delivery Mode

6 Global Precision Medicine Software Market, By Application

  • 6.1 Introduction
  • 6.2 Pharmacogenomics
  • 6.3 Rare Diseases
  • 6.4 Oncology
  • 6.5 Respiratory
  • 6.6 Immunology
  • 6.7 Central Nervous System (CNS)
  • 6.8 Other Applications

7 Global Precision Medicine Software Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmaceutical & Biotechnology Companies
  • 7.3 Healthcare Providers
  • 7.4 Research Centers and Government Institutes
  • 7.5 Other End Users

8 Global Precision Medicine Software Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 2bprecise, LLC
  • 10.2 Gene42, Inc.
  • 10.3 Syapse, Inc.
  • 10.4 Human Longevity, Inc.
  • 10.5 Fabric Genomics, Inc.
  • 10.6 Translational Software Inc.
  • 10.7 Allscripts
  • 10.8 Sophia Genetics Sa
  • 10.9 Roper Technologies
  • 10.10 Qiagen
  • 10.11 Lifeomic Health, LLC
  • 10.12 Pieriandx, Inc.

List of Tables

  • 1 Global Precision Medicine Software Market Outlook, By Region (2016-2026) ($MN)
  • 2 Global Precision Medicine Software Market Outlook, By Delivery Mode (2016-2026) ($MN)
  • 3 Global Precision Medicine Software Market Outlook, By Cloud-Based Delivery Mode (2016-2026) ($MN)
  • 4 Global Precision Medicine Software Market Outlook, By On-Premise Delivery Mode (2016-2026) ($MN)
  • 5 Global Precision Medicine Software Market Outlook, By Application (2016-2026) ($MN)
  • 6 Global Precision Medicine Software Market Outlook, By Pharmacogenomics (2016-2026) ($MN)
  • 7 Global Precision Medicine Software Market Outlook, By Rare Diseases (2016-2026) ($MN)
  • 8 Global Precision Medicine Software Market Outlook, By Oncology (2016-2026) ($MN)
  • 9 Global Precision Medicine Software Market Outlook, By Respiratory (2016-2026) ($MN)
  • 10 Global Precision Medicine Software Market Outlook, By Immunology (2016-2026) ($MN)
  • 11 Global Precision Medicine Software Market Outlook, By Central Nervous System (CNS) (2016-2026) ($MN)
  • 12 Global Precision Medicine Software Market Outlook, By Other Applications (2016-2026) ($MN)
  • 13 Global Precision Medicine Software Market Outlook, By End User (2016-2026) ($MN)
  • 14 Global Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2016-2026) ($MN)
  • 15 Global Precision Medicine Software Market Outlook, By Healthcare Providers (2016-2026) ($MN)
  • 16 Global Precision Medicine Software Market Outlook, By Research Centers and Government Institutes (2016-2026) ($MN)
  • 17 Global Precision Medicine Software Market Outlook, By Other End Users (2016-2026) ($MN)
  • 18 North America Precision Medicine Software Market Outlook, By Country (2016-2026) ($MN)
  • 19 North America Precision Medicine Software Market Outlook, By Delivery Mode (2016-2026) ($MN)
  • 20 North America Precision Medicine Software Market Outlook, By Cloud-Based Delivery Mode (2016-2026) ($MN)
  • 21 North America Precision Medicine Software Market Outlook, By On-Premise Delivery Mode (2016-2026) ($MN)
  • 22 North America Precision Medicine Software Market Outlook, By Application (2016-2026) ($MN)
  • 23 North America Precision Medicine Software Market Outlook, By Pharmacogenomics (2016-2026) ($MN)
  • 24 North America Precision Medicine Software Market Outlook, By Rare Diseases (2016-2026) ($MN)
  • 25 North America Precision Medicine Software Market Outlook, By Oncology (2016-2026) ($MN)
  • 26 North America Precision Medicine Software Market Outlook, By Respiratory (2016-2026) ($MN)
  • 27 North America Precision Medicine Software Market Outlook, By Immunology (2016-2026) ($MN)
  • 28 North America Precision Medicine Software Market Outlook, By Central Nervous System (CNS) (2016-2026) ($MN)
  • 29 North America Precision Medicine Software Market Outlook, By Other Applications (2016-2026) ($MN)
  • 30 North America Precision Medicine Software Market Outlook, By End User (2016-2026) ($MN)
  • 31 North America Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2016-2026) ($MN)
  • 32 North America Precision Medicine Software Market Outlook, By Healthcare Providers (2016-2026) ($MN)
  • 33 North America Precision Medicine Software Market Outlook, By Research Centers and Government Institutes (2016-2026) ($MN)
  • 34 North America Precision Medicine Software Market Outlook, By Other End Users (2016-2026) ($MN)
  • 35 Europe Precision Medicine Software Market Outlook, By Country (2016-2026) ($MN)
  • 36 Europe Precision Medicine Software Market Outlook, By Delivery Mode (2016-2026) ($MN)
  • 37 Europe Precision Medicine Software Market Outlook, By Cloud-Based Delivery Mode (2016-2026) ($MN)
  • 38 Europe Precision Medicine Software Market Outlook, By On-Premise Delivery Mode (2016-2026) ($MN)
  • 39 Europe Precision Medicine Software Market Outlook, By Application (2016-2026) ($MN)
  • 40 Europe Precision Medicine Software Market Outlook, By Pharmacogenomics (2016-2026) ($MN)
  • 41 Europe Precision Medicine Software Market Outlook, By Rare Diseases (2016-2026) ($MN)
  • 42 Europe Precision Medicine Software Market Outlook, By Oncology (2016-2026) ($MN)
  • 43 Europe Precision Medicine Software Market Outlook, By Respiratory (2016-2026) ($MN)
  • 44 Europe Precision Medicine Software Market Outlook, By Immunology (2016-2026) ($MN)
  • 45 Europe Precision Medicine Software Market Outlook, By Central Nervous System (CNS) (2016-2026) ($MN)
  • 46 Europe Precision Medicine Software Market Outlook, By Other Applications (2016-2026) ($MN)
  • 47 Europe Precision Medicine Software Market Outlook, By End User (2016-2026) ($MN)
  • 48 Europe Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2016-2026) ($MN)
  • 49 Europe Precision Medicine Software Market Outlook, By Healthcare Providers (2016-2026) ($MN)
  • 50 Europe Precision Medicine Software Market Outlook, By Research Centers and Government Institutes (2016-2026) ($MN)
  • 51 Europe Precision Medicine Software Market Outlook, By Other End Users (2016-2026) ($MN)
  • 52 Asia Pacific Precision Medicine Software Market Outlook, By Country (2016-2026) ($MN)
  • 53 Asia Pacific Precision Medicine Software Market Outlook, By Delivery Mode (2016-2026) ($MN)
  • 54 Asia Pacific Precision Medicine Software Market Outlook, By Cloud-Based Delivery Mode (2016-2026) ($MN)
  • 55 Asia Pacific Precision Medicine Software Market Outlook, By On-Premise Delivery Mode (2016-2026) ($MN)
  • 56 Asia Pacific Precision Medicine Software Market Outlook, By Application (2016-2026) ($MN)
  • 57 Asia Pacific Precision Medicine Software Market Outlook, By Pharmacogenomics (2016-2026) ($MN)
  • 58 Asia Pacific Precision Medicine Software Market Outlook, By Rare Diseases (2016-2026) ($MN)
  • 59 Asia Pacific Precision Medicine Software Market Outlook, By Oncology (2016-2026) ($MN)
  • 60 Asia Pacific Precision Medicine Software Market Outlook, By Respiratory (2016-2026) ($MN)
  • 61 Asia Pacific Precision Medicine Software Market Outlook, By Immunology (2016-2026) ($MN)
  • 62 Asia Pacific Precision Medicine Software Market Outlook, By Central Nervous System (CNS) (2016-2026) ($MN)
  • 63 Asia Pacific Precision Medicine Software Market Outlook, By Other Applications (2016-2026) ($MN)
  • 64 Asia Pacific Precision Medicine Software Market Outlook, By End User (2016-2026) ($MN)
  • 65 Asia Pacific Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2016-2026) ($MN)
  • 66 Asia Pacific Precision Medicine Software Market Outlook, By Healthcare Providers (2016-2026) ($MN)
  • 67 Asia Pacific Precision Medicine Software Market Outlook, By Research Centers and Government Institutes (2016-2026) ($MN)
  • 68 Asia Pacific Precision Medicine Software Market Outlook, By Other End Users (2016-2026) ($MN)
  • 69 South America Precision Medicine Software Market Outlook, By Country (2016-2026) ($MN)
  • 70 South America Precision Medicine Software Market Outlook, By Delivery Mode (2016-2026) ($MN)
  • 71 South America Precision Medicine Software Market Outlook, By Cloud-Based Delivery Mode (2016-2026) ($MN)
  • 72 South America Precision Medicine Software Market Outlook, By On-Premise Delivery Mode (2016-2026) ($MN)
  • 73 South America Precision Medicine Software Market Outlook, By Application (2016-2026) ($MN)
  • 74 South America Precision Medicine Software Market Outlook, By Pharmacogenomics (2016-2026) ($MN)
  • 75 South America Precision Medicine Software Market Outlook, By Rare Diseases (2016-2026) ($MN)
  • 76 South America Precision Medicine Software Market Outlook, By Oncology (2016-2026) ($MN)
  • 77 South America Precision Medicine Software Market Outlook, By Respiratory (2016-2026) ($MN)
  • 78 South America Precision Medicine Software Market Outlook, By Immunology (2016-2026) ($MN)
  • 79 South America Precision Medicine Software Market Outlook, By Central Nervous System (CNS) (2016-2026) ($MN)
  • 80 South America Precision Medicine Software Market Outlook, By Other Applications (2016-2026) ($MN)
  • 81 South America Precision Medicine Software Market Outlook, By End User (2016-2026) ($MN)
  • 82 South America Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2016-2026) ($MN)
  • 83 South America Precision Medicine Software Market Outlook, By Healthcare Providers (2016-2026) ($MN)
  • 84 South America Precision Medicine Software Market Outlook, By Research Centers and Government Institutes (2016-2026) ($MN)
  • 85 South America Precision Medicine Software Market Outlook, By Other End Users (2016-2026) ($MN)
  • 86 Middle East & Africa Precision Medicine Software Market Outlook, By Country (2016-2026) ($MN)
  • 87 Middle East & Africa Precision Medicine Software Market Outlook, By Delivery Mode (2016-2026) ($MN)
  • 88 Middle East & Africa Precision Medicine Software Market Outlook, By Cloud-Based Delivery Mode (2016-2026) ($MN)
  • 89 Middle East & Africa Precision Medicine Software Market Outlook, By On-Premise Delivery Mode (2016-2026) ($MN)
  • 90 Middle East & Africa Precision Medicine Software Market Outlook, By Application (2016-2026) ($MN)
  • 91 Middle East & Africa Precision Medicine Software Market Outlook, By Pharmacogenomics (2016-2026) ($MN)
  • 92 Middle East & Africa Precision Medicine Software Market Outlook, By Rare Diseases (2016-2026) ($MN)
  • 93 Middle East & Africa Precision Medicine Software Market Outlook, By Oncology (2016-2026) ($MN)
  • 94 Middle East & Africa Precision Medicine Software Market Outlook, By Respiratory (2016-2026) ($MN)
  • 95 Middle East & Africa Precision Medicine Software Market Outlook, By Immunology (2016-2026) ($MN)
  • 96 Middle East & Africa Precision Medicine Software Market Outlook, By Central Nervous System (CNS) (2016-2026) ($MN)
  • 97 Middle East & Africa Precision Medicine Software Market Outlook, By Other Applications (2016-2026) ($MN)
  • 98 Middle East & Africa Precision Medicine Software Market Outlook, By End User (2016-2026) ($MN)
  • 99 Middle East & Africa Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2016-2026) ($MN)
  • 100 Middle East & Africa Precision Medicine Software Market Outlook, By Healthcare Providers (2016-2026) ($MN)
  • 101 Middle East & Africa Precision Medicine Software Market Outlook, By Research Centers and Government Institutes (2016-2026) ($MN)
  • 102 Middle East & Africa Precision Medicine Software Market Outlook, By Other End Users (2016-2026) ($MN)
Back to Top